Pay in 4 interest-free payments of $7.34 Learn more
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15
Efficacy and safety of glucagon-like peptide-1 receptor agonists in type 2 diabetes: A systematic review and mixed-treatment comparison analysis
Oxidative stress and mitochondrial dysfunction in sepsis
As with other GLP-1 agonists, retatrutide is likely to be unsuitable for those with a family history of medullary thyroid cancer or multiple endocrine neoplasia syndrome type 2
Watch for Novos Q1 2026 earnings call (scheduled for early May) for any updates on semaglutide or amycretin expansion into non-obesity CNS indications
Alexis Cutchins, an expert in pelvic venous disease (PVD) and POTS (postural orthostatic tachycardia syndrome), to tackle one of the most misunderstood vascular conditions in complex patients
US$ 23.92
US$ 28.82
US$ 20.06
